After the Food and Drug Administration pulled its authorization of two COVID-19 antibody drugs because the treatments are highly unlikely to work against the omicron variant, Gov. Ron DeSantis of Florida misleadingly claimed the decision had been made “without a shred of clinical data” to support it. There may not be data from patients, but lab studies strongly suggest the treatments will not help omicron-infected people.
Issues: COVID-19 monoclonal antibodies
Trump on ‘Race-Based Medicine’ for COVID-19
At a rally in Arizona on Jan. 15, former President Donald Trump waded into the debate over state policies allowing health systems to consider race as a risk factor when prioritizing the allocation of limited supplies of some COVID-19 therapeutics. According to Trump, it translates to white people being denied life-saving medicines and vaccines.